✦ LIBER ✦

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer

✍ Scribed by Sekine, I; Nokihara, H; Takeda, K; Nishiwaki, Y; Nakagawa, K; Isobe, H; Mori, K; Matsui, K; Saijo, N; Tamura, T

Book ID: 109999415
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 108 KB
Volume: 98
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6604233

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly alternating therapy with irinotec

Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma

✍ William N. William Jr; James Uyeki; Faye M. Johnson; Lei Feng; Beverly O. Peeple 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views

Randomised phase III trial of carboplati

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

✍ Okamoto, H; Watanabe, K; Kunikane, H; Yokoyama, A; Kudoh, S; Shibata, T; Kunitoh 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

A phase II trial of cisplatin and irinot

A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

✍ Masahiro Tabata; Katsuyuki Kiura; Niro Okimoto; Yoshihiko Segawa; Tetsu Shinkai; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 262 KB

Irinotecan plus gemcitabine vs irinoteca

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study

✍ Georgoulias, V; Kouroussis, C; Agelidou, A; Boukovinas, I; Palamidas, P; Stavrin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

Phase II trial of gemcitabine plus cispl

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer

✍ Yu, Hai-feng; Wu, Feng-qin; Fan, Yun; Lin, Neng-ming; Ma, Sheng-lin; Luo, Lü-hon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 Chinese ⚖ 317 KB